[Dipeptidyl peptidase 4 inhibitors and the risk of cardiovascular disease: The case of sitagliptin]
- PMID: 26524980
- DOI: 10.1016/j.semerg.2015.09.011
[Dipeptidyl peptidase 4 inhibitors and the risk of cardiovascular disease: The case of sitagliptin]
Comment on
-
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.N Engl J Med. 2015 Jul 16;373(3):232-42. doi: 10.1056/NEJMoa1501352. Epub 2015 Jun 8. N Engl J Med. 2015. PMID: 26052984 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources